Clinical Trial Update: CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update from the University of California, San Francisco evaluating probiotics to treat anal pre-cancer (anal intraepithelial ne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Anal Intraepithelial Neoplasia
• Hpv-related Squamous Cell Carcinoma

Drugs mentioned

• Probiotics

Snippet

Sponsor: University of California, San Francisco | Conditions: HSIL, High Grade Squamous Intraepithelial Lesion, HPV-Related Squamous Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING